CCB International, the venture unit of China Construction Bank, led a CNY750m (USD116m)  Series C for China-based DNA sequencing company Geneplus Technology, with participation from Fortune Capital, GGV Capital, Suzhou Harvest Capital, Baidu Ventures, Alibaba’s AliHealth and JM Capital. Read more